Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity

BMC Cell Biology

Volumn 7, Issue , 2006, Pages

  Aho, Teija L T ^a   Sandholm, Jouko ^a   Peltola, Katriina J ^a   Ito, Yoshiaki ^b   Koskinen, Päivi J ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; PROTEIN KINASE PIM 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMOGENESIS; NONHUMAN; PRECIPITATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CORE BINDING FACTOR ALPHA SUBUNITS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIESIS; HUMANS; JURKAT CELLS; MICE; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-PIM-1; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA; MURINAE;

EID: 33744774483     PISSN: 14712121     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-7-21     Document Type: Article

References (43)

1. Allen JD, Berns A: Complementation tagging of cooperating oncogenes in knockout mice. Semin Cancer Biol 1996, 7:299-306. Review
2. Acton D, Domen J, Jacobs H, Vlaar M, Korsmeyer S, Berns A: Collaboration of pim -1 and bcl -2 in lymphomagenesis. Curr Top Microbiol Immunol 1992, 182:293-298.
3. Blyth K, Terry A, Mackay N, Vaillant F, Bell M, Cameron ER, Neil JC, Stewart M: Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene 2001, 20:295-302.
4. Saris CJM, Domen J, Berns A: The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J 1991, 10:655-664.
5. Dautry F, Weil D, Yu J, Dautry-Varsat A: Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem 1988, 263:17615-17620.
6. Lilly M, Le T, Holland P, Hendrickson SL: Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene 1992, 7:727-732.
7. Matikainen S, Saraneva T, Rönni T, Lehtonen A, Koskinen PJ, Julkunen I: Interferon-α activates multiple STAT proteins and up-regulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes in human T cells. Blood 1999, 93:1980-1991.
8. Rainio EM, Sandolm J, Koskinen PJ: Cutting edge: Transcriptional activity of NFATc1 is enhanced by Pim-1 kinase. J Immunol 2002, 168:1524-1527.
9. Leverson JD, Koskinen PJ, Orrico FC, Rainio EM, Jalkanen KJ, Dash AB, Eisenman RN, Ness SA: Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell 1998, 2:417-425.
10. Rainio EM, Ahlfors H, Carter KL, Ruuska M, Matikainen S, Kieff E, Koskinen PJ: Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. Virology 2005, 333:201-206.
11. Chen XP, Losman JA, Cowan S, Donahue E, Fay S, Vuong BQ, Nawijn MC, Capece D, Cohan VL, Rothman P: Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci USA 2002, 99:2175-2180.
12. Peltola KJ, Paukku K, Aho TLT, Ruuska M, Silvennoinen O, Koskinen PJ: Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood 2004, 103:3744-3750.
13. Bachmann M, Möröy T: The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 2005, 37:726-730. Review
14. Van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck N: Nomenclature for Runt-related (RUNX) proteins. Oncogene 2004, 23:4209-4210.
15. Coffman JA: Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol Int 2003, 27:315-224. Review
16. de Bruijn MFTR, Speck NA: Core-binding factors in hematopoiesis and immune function. Oncogene 2004, 23:4238-4248. Review
17. Gergen JP, Butler BA: Isolation of the Drosophila segementation gene runt and analysis of its expression during embryogenesis. Genes Dev 1988, 2:1179-1193.
18. Ito Y: Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells 1999, 4:685-696. Review
19. Kanno T, Kanno Y, Chen L-F, Ogawa E, Kim W-Y, Ito Y: Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol Cell Biol 1998, 18:2444-2454.
20. Bae S-C, Lee YH: Phosphorylation, acetylation and ubiquitination: The molecular basis of RUNX regulation. Gene 2005 in press. Review
21. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991, 88:10431-10434.
22. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE: Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet 1997, 15:303-306.
23. Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR: Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 1998, 91:3134-3143.
24. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
25. Cameron ER, Blyth K, Hanlon L, Kilbey A, Mackay N, Stewart M, Terry A, Vaillant F, Wotton S, Neil JC: The Runx genes as dominant oncogenes. Blood Cells Mol Dis 2003, 30:194-200. Review
26. Busson-Le Coniat M, Nguyen Khac F, Daniel MT, Bernard OA, Berger R: Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001, 32:244-249.
27. Penther D, Preudhomme C, Talmant P, Roumier C, Godon A, Mechinaud F, Milpied N, Bataille R, Avet-Loiseau H: Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 2002, 16:1131-1134.
28. Hollenberg SM, Sternglanz R, Cheng PF, Weintraub H: Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol Cell Biol 1995, 15:3813-3822.
29. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ: The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 1993, 7:555-569.
30. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ: Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 2004, 571:43-49.
31. Lu J, Maruyama M, Satake M, Bae SC, Ogawa E, Kagoshima H, Shigesada K, Ito Y: Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol Cell Biol 1995, 15:1651-1661.
32. Le XF, Groner Y, Kornblau SM, Gu Y, Hittelman WN, Levanon D, Mehta K, Arlinghaus RB, Chang KS: Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor α-dependent signaling pathway. J Biol Chem 1999, 274:21651-21658.
33. Tanaka T, Kurokawa M, Ueki K, Tanaka K, Imai Y, Mitani K, Okazaki K, Sagata N, Yazaki Y, Shibata Y, Kadowaki T, Hirai H: The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation function. Mol Cell Biol 1996, 16:3967-3979.
34. Imai Y, Kurokawa M, Yamaguchi Y, Izutsu K, Nitta E, Mitani K, Satake M, Noda T, Ito Y, Hirai H: The corepressor mSin3A regulates phosphorylation-induced activation, intranucleosomal location, and stability of AML1. Mol Cel Biol 2004, 24:1033-1043.
35. Palaty CK, Kalmar G, Tai G, Oh S, Amankawa L, Affolter M, Aebersold R, Pelech SL: Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase. J Biol Chem 1997, 272:10514-10521.
36. Vaillant F, Blyth K, Andrew L, Neil JC, Cameron ER: Enforced expression of Runx2 perturbs T cell development at a stage coincident with β-selection. J Immunol 2002, 169:2866-2874.
37. Schmidt T, Karsynky H, Rödel B, Zevnik B, Elsässer H-P, Möröy T: Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with β-selection. EMBO J 1998, 17:5349-5369.
38. Jacobs H, Krimpenfort P, Haks M, Allen J, Blom B, Démollière C, Kruisbeek A, Spits H, Berns A: PIM1 reconstitues thymic cellularity in Interleukin 7- and Common γ chain-mutant mice and permits thymocyte maturation in Rag- but not in CD3γ-deficient mice. J Exp Med 1999, 190:1059-1068.
39. Leduc I, Karsynky H, Mathieu N, Schmidt T, Verthuy C, Ferrier P, Möröy T: The Pim-1 kinase stimulates maturation of TCRβ-deficient T cell progrenitors: implications for the mechanism of Pim-1 action. Int Immunol 2000, 12:1389-1396.
40. Sato T, Ito R, Nunomura S, Ohno S, Hayashi K, Satake M, Habu S: Requirement of transcription factor AML1 in proliferation of developing thymocytes. Immunol Lett 2003, 89:39-46.
41. Mikkers H, Allen J, Knipscheer P, Romeyn L, Hart A, Vink E, Berns A: High-throughput retroviral tagging to identify components of specific sigaling pathways in cancer. Nat Genet 2002, 32:153-159.
42. Ylikorkala A, Avizienyte E, Tomlinson IP, Tiainen M, Roth S, Loukola A, Hemminki A, Johansson M, Sistonen P, Markie D, Neale K, Phillips R, Zauber P, Twama T, Sampson J, Järvinen H, Mäkelä TP, Aaltonen LA: Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet 1999, 8:45-51.
43. Northrop JP, Ullman KS, Crabtree GR: Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 1993, 268:2917-2923.